LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Reports New Gold Discovery at Bartec, Expanding Swanson Deposit Potential in Abitibi
October 6, 2026 — Disseminated on behalf of LaFleur Minerals Inc. and may include paid advertising.
The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.
RSS Feed for InvestorBrandNetwork (IBN)October 6, 2026 — Disseminated on behalf of LaFleur Minerals Inc. and may include paid advertising.
October 6, 2026 — In a recent InvestorNews column, metals market analyst Jack Lifton discussed Greenland’s rare earth projects, noting Greenland Mines’ positioning in the space. The column arrives at a pivotal moment for the company, which closed its acquisition of Sarfartoq on September 1, 2026.
October 6, 2026 — MindWave is developing and commercially providing the infrastructure behind an ecosystem centered on MindChain, MindWaveDAO and $NILA. MindChain serves as the EVM-compatible Layer 2, while purpose-built industry networks provide specialized environments for real-world applications.
October 6, 2026 — Telomir Pharmaceuticals (NASDAQ: TELO) announced an approximately $5. 6 million private investment in public equity (“PIPE”) financing through the issuance of 4,843,300 common shares at $1.
October 6, 2026 — Earth Science Tech operates several subsidiaries, including real estate and asset management company Avenvi LLC Avenvi boasts expertise across various segments of the real estate industry, including identifying development opportunities and facilitating end-user property acquisitions Avenvi also manages investments on behalf of ETST and provides the critical physical infrastructure for ETST’s expanding pharmacy operations Earth Science Tech (OTCQB: ETST), a strategic holding company that brings together innovative businesses across the healthcare, pharmacy, technology and telemedicine, real estate, and consumer products spaces, operates Avenvi LLC, a real estate and asset management arm. Like its parent company, Avenvi is diversified, boasting expertise across various segments of the real estate industry and representing ETST’s diversification into hard assets.
October 6, 2026 — NanoViricides, Inc. (NYSE American: NNVC) announced that it will present Oct.
October 6, 2026 — Quantum BioPharma (NASDAQ: QNTM) entered into a Study Start-Up Agreement (“SUA”) with the clinical research business of Thermo Fisher Scientific to implement its Phase 2 clinical trial of Lucid-21-302 (“Lucid-MS”) for multiple sclerosis (“MS”). The agreement initiates formal study start-up activities following FDA clearance to proceed with the trial.
October 6, 2026 — Amazon has signed a new power agreement backing a wind farm planned for Shetland, adding to a UK renewable portfolio that now runs past 50 separate projects. The deal with Norwegian energy firm Statkraft covers the Mossy Hill site, which is on track to come online in late 2030, and gives the developer the backing needed to push the project toward actual construction.
October 6, 2026 — In March, Iran struck AWS data centers and associated infrastructure located in the UAE. The following month, another facility owned by Amazon was also targeted in Bahrain.
October 6, 2026 — Greenland Mines (NASDAQ: GRML; FSE: HK6) announced that its board of directors authorized a $20 million share repurchase program as part of an updated capital allocation strategy focused on advancing its core mineral projects, maintaining liquidity and maximizing long-term shareholder value. Following its recent raise of more than $59 million, the company said it is positioned to fund planned work at Sarfartoq and Skaergaard through targeted 2027 milestones while retaining flexibility to repurchase shares.
October 6, 2026 — The crypto sector poured roughly $8 million in the first six months of 2026 into lobbying efforts tied to U. S.
October 6, 2026 — Europe’s online shopping market is still growing, but not as fast as before. According to the latest European E-commerce Report 2026, ecommerce sales across the continent are forecast to rise by 5% in 2026, reaching €961 billion ($1.
October 6, 2026 — Rezolve Ai (NASDAQ: RZLV) received Court approval for its proposed capital reduction, an important step toward implementing its previously announced share repurchase program of up to $300 million. The approval follows shareholder approval of the capital reduction, with the company expecting to commence repurchases after remaining procedural requirements become effective, subject to market conditions, available capital, liquidity, capital allocation priorities and other relevant factors.
October 6, 2026 — Disseminated on behalf of SuperQ Quantum Computing Inc. and may include paid advertisements.
October 6, 2026 — Rezolve Ai (NASDAQ: RZLV) is hosting its Investor Day at Nasdaq MarketSite in New York City, where management will present the company strategy, market opportunity, commercial model, growth drivers and platform for agentic commerce. In conjunction with the event, Rezolve Ai published its US AI Visibility Study 2026, examining how leading AI assistants present 2,047 U.
October 6, 2026 — Beeline Holdings (NASDAQ: BLNE) provided a preliminary update on third-quarter 2026 performance, expecting revenue to reach the second-highest quarterly level in company history and the highest since 2021, while achieving its highest margins to date. Beeline also expects its net loss to decline from Q2, adjusted EBITDA loss to improve to its lowest level in five years and its quarter-end cash position to be at least 50% higher than at the end of Q2.
October 6, 2026 — Datavault AI (NASDAQ: DVLT) appointed Christopher R. Hardt to its board of directors as an independent director, effective Oct.
October 6, 2026 — A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) has completed its acquisition of Hedia, an Israeli retail media company with fiscal 2025 audited revenue of approximately $20 million.
October 6, 2026 — Kairos Pharma (NYSE American: KAPA) announced positive interim efficacy data from its ongoing Phase 2 trial evaluating ENV-105 in combination with apalutamide in patients with metastatic castration-resistant prostate cancer. The analysis showed a statistically significant difference in progression-free survival, with median PFS of 17.
October 6, 2026 — Disseminated on behalf of BTQ Technologies Corp. and may include paid advertisements.